sprite-preloader
Anzeige
Mehr »
Montag, 23.07.2018 Börsentäglich über 12.000 News von 588 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrPureTech lifted by news of Roche deal
FrUK drug advisors recommend rescheduling of medical cannabis
FrAllergan, Molecular Partners' AMD drug non-inferior to Lucentis
FrNICE backs radionuclide therapy for some neuroendocrine tumours
DoBe recognised for the part you play in targets being met
DoIndustry shows support for new Medical & Scientific Excellence Awards
DoWant to make a difference? Enter the new Charity Challenge
DoFly your company's flag - ENTER NOW
DoSub-cutaneous form of Entyvio hits PhIII safety, efficacy goals
DoOwlstone Medical appoints five leading experts to Scientific Advisory Board
DoKisqali wins speedy US breast cancer nod
DoFour pharmas named for breaching ABPI Code of Practice
DoDementia accounts for 13 percent of total UK deaths
DoNovartis bags rights to Galapagos/MorphoSys atopic dermatitis drug
MiSilence Therapeutics appoints David Horn Solomon as CEO
MiNICE calls for quicker treatment of kidney stone patients in pain
MiRecord numbers taking part in life sciences industry research
MiUS approves Janssen's HIV pill Symtuza
Mi11 London makes 3 new senior hires
DiRoche's antiviral hits flu targets in PhIII trial
DiPfizer kicks off PhIII programme for haemophilia B gene therapy
DiUK panel says human embryo editing 'morally permissable'
DiNICE issues cerebral palsy guideline for adults
DiEU approval for Akcea/Ionis' rare disease therapy
16.07.Enter now and showcase your talents industry-wide